Siloton Wins £8.4M from Innovate UK to Take GiraffeOCT into Clinical Use
Siloton will receive £8.4 million in funding from Innovate UK over two years to advance GiraffeOCT, its OCT technology based on quantum photonic integrated circuits, toward clinical use. The funding is expected to shorten the development timeline by about two years.
Why we recommend it: The original article lays out the funding path for moving photonic integrated OCT from the lab to the clinic, serving as a reference for commercializing medical optical devices

